ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,980, issued on Nov. 4, was assigned to ASKGENE PHARMA INC. (Camarillo, Calif.).
"IL-21 prodrugs and methods of use thereof" was invented by Yuefeng Lu (Newbury Park, Calif.) and Chunxiao Yu (Santa Barbara, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are IL-21 prodrugs and methods of making and using thereof for stimulating the immune system, or treating cancer or an infectious disease."
The patent was filed on July 25, 2019, under Application No. 17/262,940.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%...